Diabetes: Scenario, nutrition and enteral nutritional therapy
27th International Conference on Diabetes and Endocrinology
May 16-17, 2019 | Prague, Czech Republic
Pollyana Araujo Correa
Nestle Health Science, Brazil
Scientific Tracks Abstracts : J Diabetol
Abstract:
Diabetes mellitus (DM) is an important and growing health
problem for all countries, regardless of their degree of
development. In 2015, the International Diabetes Federation
(IDF) estimated that 8.8% (95% confidence interval: 7.2 to
11.4) of the world population aged 20-79 years (415 million
of people) lived with diabetes. If current trends persist, the
number of people with diabetes was projected to exceed 642
million by 2040. The increase in the prevalence of diabetes is
associated with several factors, such as: rapid urbanization,
epidemiological transition, nutritional transition, greater
frequency of sedentary lifestyle, greater frequency
of overweight, growth and population aging, and also
greater individual’s survival with diabetes. The World Health
Organization estimates that high glycemia is the third major
factor in the cause of premature mortality, surpassed only
by increased blood pressure and tobacco use. Nutritional
care in diabetes mellitus (DM) is one of the most challenging
parts of treatment and lifestyle change strategies, as well
as in hospitalized patients in Enteral Nutritional Therapy.
International recommendations on enteral nutritional
therapy (NER) in diabetes were initiated in 1998, when the
ADA and the European Association for the Study of Diabetes
(EASD) developed in Chicago, consensus that has established
proposals for this purpose. The latest consensus published by
the ADA recommends the presence of a registered dietitian
in the hospital team to conduct a realistic plan on nutritional
therapy. A recent study including patients with DM2, admitted
to intensive care units (ICUs), showed that the use of a
specialized formula in glycemic control was correlated with
a reduction in mortality and with better economic results.
Biography:
Pollyana Araújo Corrêa has graduated in nutrition at the age of 22 years from Universidade Católica de Brasília and she also had a graduation in Business Management, Comptroller and Corporate Finance from IPOG, BR. She is a technical advisor of clinical nutrition at Nestlé Health Science in Brasília, BR, working with enteral nutritional therapy in various pathologies.
E-mail: pollyana.correa@gmail.com
PDF HTML